Skip to main content
. 2020 Mar 23;21(6):2215. doi: 10.3390/ijms21062215

Figure 1.

Figure 1

Analysis of IL-17A expression and survival of IL-17A high and low expressing tumors. (a) Western blot of IL-17RA protein expression in tumor (T) and corresponding non-tumor tissue (N) from nine human PDAC samples (P1–P9). (b) Western blot of IL-17RA protein expression in human PDAC cell lines L3.6pl, MIA PaCa-2, and patient derived PDAC cell line TBO368 with and without IL-17A stimulation (0, 20, 40 ng/mL) for 48 h.